A new wave of controversy dominated the Indian media's attention after Podcaster Ranveer Allahbadia made a distasteful ...

The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

National Human Rights Commission wrote to YouTube seeking removal of the videos featuring Ranveer Allahbadia. Interestingly, ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics and machine learning company Zymergen (bought by Ginkgo Bioworks in 2022), ...

After the mainland of China, South Korea, Australia and Singapore, Taiwan market is the fifth APAC market in which XPOVIO® has been approved for public health insurance coverage. XPOVIO® is expected ...

A report from Zhongshan Daily & Zhongshan International Communications Center: In July 2024, the elderly health care vouchers of Hong Kong could be used in Zhongshan Chenxinghai Hospital. Zhongshan ...

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships.

BSE has emerged as the top performer in the Nifty 500 Index, surging by 42 percent. Amber Enterprises and Zensar Technologies ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.